SlideShare ist ein Scribd-Unternehmen logo
1 von 37
Downloaden Sie, um offline zu lesen
What Parents Can Do

         April 10-12, 2012
  Walt Disney World Swan Resort
Accepted Learning Objectives:
1. Compare mixed-method studies that focus
on behavioral factors related to drug use and
abuse, especially among youth and
adolescents.
2. Outline proven comprehensive strategies for
combating prescription drug abuse through
the development of community partnerships.
3. Express the impact of prescription drug
abuse on families and communities through
anecdotal personal stories.
Disclosure Statement
•  All presenters for this session, Dr. Carol
   J. Boyd, Dr. Gary Martin, and Karen
   Perry, have disclosed no relevant, real
   or apparent personal or professional
   financial relationships.
April 2012




         Nonmedical Use of Controlled
          Medications among Teens

                       Carol J Boyd, PhD, MSN, FAAN
                    Deborah J Oakley Professor, Nursing
                     Research Professor, UM Substance
                         Abuse Research Center
                        Co-Director, SHARP Center




                                                          4
Purpose
To meet the objectives, I will:

•    Review the various ways in which the nonmedical use of
     controlled medications manifests itself in the adolescent
     population in the United States.

•  Present definitions and case examples in order to highlight the
   complexity of this form of substance abuse.

•     Using Problem Behavior Theory as a framework, we will focus
     on the behavioral and social problems that often accompany
     some forms of nonmedical use of controlled medications.



                                                                     5
Prescription Drug Abuse
•  Medical misuse of controlled medications (drugs):
    –  use of a controlled medication by the person (and for the purpose)
       intended by the prescribing clinician; however, the medication is:

        •  NOT used in the prescribed dose and/or not taken within a prescribed time
           interval. It may also a different route of administration.

•  Nonmedical use of controlled medications (drugs):
    –  use of a controlled medication to “get high”/create an altered state or
    –  for reasons other than what the prescribing clinician intended.

•  Diversion of prescription medications (drugs):
    –  exchange of prescription medications that leads to the use of these drugs:

        •  by people other than whom the prescribing clinician intended or
        •  under conditions associated with “doctor shopping”/
           misrepresentation
        •  by theft or drug dealing.



                                                                                       6
Differences among
 nonmedical users




                    7
Subtypes of Nonmedical Users

                Non-medical use of
               Controlled Medications

                                          Medication
                Diverted
                                          Misuse

  Sensation-                                          Self-Treaters
  Seekers                                             (With own Rx)
  (No Rx)                             Sensation-
                  Self-Treaters
                  (No Rx)
                                       Seekers
                                      (With own Rx)




                                  8
CASE EXAMPLES


What do these subtypes look
           like?



                              9
CASE	
  EXAMPLES	
  




         10
Case Example #1
A student is prescribed an
SSRI and an anxiolytic
(benzodiazepine) for
Generalized Anxiety
Disorder. He has been
taking these medications for
two years. During his junior
year, the young man
doubled his dose of the
benzodiazepines (without
physician knowledge) in
order to reduce his anxiety;
his symptoms were
perceived as intolerable
and he was seeking relief.

                                11
Case Example #1: Behavior and Attributes


     BEHAVIOR:                         ATTRIBUTES:

     The intentional change          •  Has his/her own
                                        prescription;
     in the dosing of a
     prescribed, scheduled           •  Aware of the correct
                                        dosing instructions;
     medication for the
     purpose of relieving the        •  Motive is to reduce
                                        symptoms from a
     symptoms for which the             medical disorder.
     medication was
     originally prescribed.



Self-treatment w/ own Rx        12
Case Example #2

	
  A young man is
    prescribed a stimulant for
    his ADHD and to assist
    with concentration. He
    takes the medication as
    prescribed during the
    week; on the weekend
    he often snorts his
    medicine and goes out
    drinking with friends.
                          13
Case Example #2: Behavior and Attributes 	
  
                              ATTRIBUTES:
BEHAVIOR:

                              •  Administered in ways other
The incorrect use of          than prescribed;
a prescribed                  •  Used in higher doses either
medication by a               by increasing the dosage or
patient with a                by decreasing the time-
prescription.	
  	
           interval between doses;
                              •  Motive is to enhance the
                              medication’s effect in order
                              to get high, experience an
                              altered state or increase
                              performance.
Sensation-seeking w/ own rx

                              14
Case Example #3
On a Friday afternoon, a
16 year old teen, an honor
student, is planning to
attend “Homecoming”
with her new boyfriend.
Four hours before the
event, she develops a
severe migraine and is
nauseated and dizzy. In
tears, she asks her mother
for help. Her mother gives
her two hydrocodone
tablets (left over from her
own surgery). The teen
went to the event and
“had a great time.”
                          15
Case Example #3: Behavior and Attributes

BEHAVIOR:                          ATTRIBUTES:
                                   •  No prescription;
   The intentional use of          •  Perceived barriers to
   someone else’s                     medical care (a
   prescription medication            prescription is not
   for the purpose of                 available);
   alleviating symptoms            •  Motive to relieve a
   that may be related to             condition for which the
   a health problem.                  medication, when
                                      prescribed, is generally
                                      intended.	
  	
  


Self-treatment w/o legal rx   16
Case Example #4
A girl with a history of
alcohol abuse is
given an oxycodone
tablet by a friend; she
wants to experiment
to see “what it does”.
She crushes and
snorts the pill. The girl
continues to buy
“Oxy” from friends
when she wants to
party.
                                17
Case Example #3: Behavior and Attributes

 DEFINITION:                      ATTRIBUTES:
                                  •  No prescription;
 The use of a                     •  May involve using in
 controlled                          combination with other
 medication to                       drugs
 experiment, to get               •  May involve delivering the
 high or to create an                medication in a wrongful
 altered state.                      manner (e.g. IV, skin-
                                     popping, snorting, smoking).
                                  •  Motive is to experiment, get
                                     high or to alleviate
                                     withdrawal symptoms

 Sensation-seeking w/o legal rx
                                   18
 Should it Matter?
Our PRELIMINARY work showed:
  –  Increased risk with some motivations
  –  When respondents report using their
     scheduled medications correctly, there is no
     greater risk for using illicit drugs than non-users.
  –  When respondents divert their medications,
     they are more likely to engage in other forms
     of substance use.
  –  Sharing/selling and taking/borrowing/buying
     involve differential health and social
     consequences.
                            19
Prescription Drug Misusers & Abusers:
                 Subtypes
Person does not possess                        Person does possess legal
legal prescription                             prescription



Sensation-seeking:               Sensation-seeking:
get high, experiment, or create  get high, experiment, or create
altered state (w/ someone else’s altered state (w/ own meds)
meds)
Self-treating:                                 Self-treating:
self-treat symptoms of actual or               self-treat symptoms of actual
perceived health condition (w/                 or perceived health condition
someone else’s meds)                           (w/ own meds)


               Boyd CJ, McCabe SE. Subst Abuse Treat Prev Policy. 2008,3:22.
IS THIS CONCEPTUALIZATION
    SUPPORTED BY DATA?




    Do subtypes matter




.
Background
                               •    Boyd, C.J., McCabe, S.E., & Teter, C.J. (2006).
                                    Medical and Nonmedical Use of Prescription Pain
                                    Medication by Youth in a Detroit-Area Public School
                                    District. Drug and Alcohol Dependence, 81(1):
•  In the past, our team has        37-45.

   published on motivations,   •    Boyd, C.J., McCabe, S.E., Cranford, J.A., & Young,
   diversion and problem            A.M. (2006). Adolescents’ Motivations to Abuse
                                    Prescription Medications. Pediatrics, 118:2472-2480.
   behaviors associated with   •    Boyd, C.J., McCabe, S.E., Cranford, J.A., & Young,
   the nonmedical use of            A.M. (2007). Gender Differences in Prescription
                                    Drug Abuse and Diversion among Adolescents in a
   scheduled medications by         Southeast Michigan School-District. Archives of
                                    Adolescent and Pediatric Medicine, 161: 276-281.
   adolescents.
                               •    McCabe, S.E., Boyd, C.J., Young, A.M. (2007)
                                    Medical and Nonmedical Use of Prescription Drugs
                                    among Secondary School Students. Journal of
•  Our procedures and               Adolescent Health, 40: 76-83.

   measures have been          •    Boyd, C.J., Young, A.M., Grey, M., & McCabe, S.E.
                                    (2009). Adolescents’ nonmedical use of prescription
   described previously in          medications and other problem behaviors. Journal
                                    of Adolescent Health. 45, 543-550.
   great detail.
                               •    Young, A.M, Grey, M., McCabe, S.E., Boyd, C.J. (In
                                    Press). Adolescent Sexual Assault and the Medical
                                    and Nonmedical Use of Prescription Medication.
                                    Journal of Addiction Nursing.




                                                                 NIH GRANT R01 DA024678
Problem Behaviors and Nonmedical
              Use

                .




                                   23
Conceptual Model:
     Problem Behavior Theory (Adapted from Jessor)

                                                                                                                                                Substance
                                                                                            Medical Misuse/                                       Abuse
                                                                                            Non-medical Use                                      Problems
                                  Personal Risk factors        • Medical/Psychiatric care
                                                                                              of Rx Drugs
      • Social Environment                                     • Medications                                      • Truancy
      • Perceived Environment                                  • Peers/social network                             • Gambling
      • Demographic             • Medical problems                                                                • Early sexual activity
                                                               • Family Support                                                             • CRAFFT
        Characteristics
      • Genetics/biology
                                • Emotional problems
                                • Resilience/Vulnerability
                                                               • School activities          • MOTIVATIONS         • Illicit drug use        • DAST-10
                                                               • School-based counseling    • Sensation-Seeking
      • Psychological
      • Personality                                                                         • Self-treatment



                 Domains
                                                                                                                             Problem
                                                                      Symptom                                               Behaviors
                                                                        relief




Boyd, C.J., Young, A., Grey, M., & McCabe, S.E., 2009. Adolescents’ nonmedical use of
prescription medications and other problem behaviors. J Adol. Health 45, 539-540.

                                                             Boyd (PI) NIH Grant RO1 DA024678
Hypothesis

Youth engaging in nonmedical use for
sensation-seeking are more likely to report
other problem behaviors vs. those who are:
 –  non-users (who were never prescribed an
    opioid)
 –  medical users (who were prescribed but
    used correctly)
 –  self-treaters (who engaged in nonmedical
    use for self-treatment)


           Boyd CJ, et al. J Adolesc Health. 2009;45:543-50.
Problem Behaviors and Nonmedical Use
•  Administered to grades 7-12 (912 respondents
   in 2007) southeastern Michigan school district
   –  Random sample, Web-based, self-administered
   –  Secondary Student Life Survey
“On how many occasions in past 12 months have
you used the following types of drugs, not prescribed
to you?” (also asked about lifetime use)

   –    Sleeping medication
   –    Sedative/anxiety medication
   –    Stimulant medication
   –    Pain medication

                   Boyd CJ, et al. J Adolesc Health. 2009;45:543-50.
Sample Characteristics

Female: 52.6%   Mean Age: 14.97 (1.74)
  (480)
                Black: 53.8% (490)
Male: 47.4%
                White: 43.5% (396)
 (432)
                Asian American: 1.4% (13)
Total: 912      Hispanic/ Latino/a: .7% (6)
                American/Alaskan Native: .7% (6)




                                              27
Procedure: Secondary Student Life Survey
•  Data were collected, w/web-based survey
•  All students in one school district (7th-12th grades)
•  968 students returned consent forms (64% response
   rate)
•  IRB approval was obtained, hooded computers
   used
•  The Secondary Student Life Survey (SSLS) is
   maintained on a hosted secure Internet site running
   under the secure sockets layer (SSL) protocol to
   insure data were safely transmitted.


                                                      28
Measures
•  Demographic information.
•  Binge drinking. Illicit drug use.
•  Illicit drug use was assessed
•  Gambling.
•   School discipline.
•  Sexual activity.
•   Depression (CESD scale). Depression symptoms were
   measured by the Center for Epidemiological Studies
   Depression Scale. 
•  Impulsivity. The Impulsivity subscale, part of the
   Impulsivity/Sensation-Seeking scale (Imp-SS) of the
   Zuckerman-Kuhlman Personality Questionnaire.


                                                         29
Characteristics of Respondents Past-Year Use
(Pain, Stimulant, Anti-anxiety/Sedative & Sleep)

          Secondary Student Life Survey




           Boyd CJ, et al. J Adolesc Health. 2009;45:543-50.
Prevalence of Medical & Nonmedical Use

                     Medical use                                              Nonmedical use




*Often for third molar extractions

                          Boyd CJ, et al. J Adolesc Health. 2009;45:543-50.
Past-yr Problem-Behaviors:
          Medical & Nonmedical Users
Secondary Student Life Survey




     *P<.05 vs. all 3 other gps
     †P<.05   vs. nonusers & medical users                   *
     Non-users: reference gp set to “0”
                                                                           *

                                                                  *




                           Boyd CJ, et al. J Adolesc Health. 2009;45:543-50.
Summary
•  The nonmedical use of controlled
   medications involves a variety of
   behaviors;
•  Consequences may be different for self-
   treaters versus sensation-seekers;
•  Prevention experts must decide behaviors
   they are targeting;
•  Everyone plays a role in prevention
•  Consider the ABC’s…

                                              33
Our team’s next project

                      ABC’s and Prevention

Boyd, C.J., Anderson, K.G., Rieckman, T. (2011) ABC’s of Controlled Medications: What Patients
  Need to Know about their Prescription Pain Medicine (Commentary), Journal of Addictions
                                        Nursing. 22:1–3.
QUESTIONS?




   THANK YOU

Weitere ähnliche Inhalte

Was ist angesagt?

BZDs Patients Substance Abuse97-03Mode
BZDs Patients Substance Abuse97-03ModeBZDs Patients Substance Abuse97-03Mode
BZDs Patients Substance Abuse97-03Modezuschette
 
Power point SUD SW662
Power point SUD SW662Power point SUD SW662
Power point SUD SW662AliciaHart11
 
An Exploration of Depressive Symptoms in Hepatitis CPatients Taking Interfero...
An Exploration of Depressive Symptoms in Hepatitis CPatients Taking Interfero...An Exploration of Depressive Symptoms in Hepatitis CPatients Taking Interfero...
An Exploration of Depressive Symptoms in Hepatitis CPatients Taking Interfero...Jocelyn Red Red
 
Depression and the heart pamphlet
Depression and the heart pamphletDepression and the heart pamphlet
Depression and the heart pamphlethelix1661
 
Ten Most Common Mistakes in Clinical Trial Interpretation
Ten Most Common Mistakes in Clinical Trial InterpretationTen Most Common Mistakes in Clinical Trial Interpretation
Ten Most Common Mistakes in Clinical Trial Interpretationclinicaltrialist
 
Navigating OCD in the world of 12 step Substance Use Disorder (SUD) Recovery
Navigating OCD in the world of 12 step Substance Use Disorder (SUD) RecoveryNavigating OCD in the world of 12 step Substance Use Disorder (SUD) Recovery
Navigating OCD in the world of 12 step Substance Use Disorder (SUD) RecoveryStaceyConroy3
 
Breakout 3.4 How to support the psychological needs of patients with COPD - K...
Breakout 3.4 How to support the psychological needs of patients with COPD - K...Breakout 3.4 How to support the psychological needs of patients with COPD - K...
Breakout 3.4 How to support the psychological needs of patients with COPD - K...NHS Improvement
 
Ten Most Common Mistakes in Clinical Trial Interpretation - Slidecast
Ten Most Common Mistakes in Clinical Trial Interpretation - SlidecastTen Most Common Mistakes in Clinical Trial Interpretation - Slidecast
Ten Most Common Mistakes in Clinical Trial Interpretation - Slidecastclinicaltrialist
 
Psychodynamics and Developmental Psychology of the Borderline Patient - a Rev...
Psychodynamics and Developmental Psychology of the Borderline Patient - a Rev...Psychodynamics and Developmental Psychology of the Borderline Patient - a Rev...
Psychodynamics and Developmental Psychology of the Borderline Patient - a Rev...Ed Shapiro
 
Critical appraisal of evidence/journal club
Critical appraisal of evidence/journal clubCritical appraisal of evidence/journal club
Critical appraisal of evidence/journal clubdassoumitradr
 
Moti messiah - ULD buprenorphine for suicidal ideation
Moti messiah - ULD buprenorphine for suicidal ideationMoti messiah - ULD buprenorphine for suicidal ideation
Moti messiah - ULD buprenorphine for suicidal ideationמוטי משיח
 

Was ist angesagt? (12)

BZDs Patients Substance Abuse97-03Mode
BZDs Patients Substance Abuse97-03ModeBZDs Patients Substance Abuse97-03Mode
BZDs Patients Substance Abuse97-03Mode
 
Power point SUD SW662
Power point SUD SW662Power point SUD SW662
Power point SUD SW662
 
An Exploration of Depressive Symptoms in Hepatitis CPatients Taking Interfero...
An Exploration of Depressive Symptoms in Hepatitis CPatients Taking Interfero...An Exploration of Depressive Symptoms in Hepatitis CPatients Taking Interfero...
An Exploration of Depressive Symptoms in Hepatitis CPatients Taking Interfero...
 
Depression and the heart pamphlet
Depression and the heart pamphletDepression and the heart pamphlet
Depression and the heart pamphlet
 
Ten Most Common Mistakes in Clinical Trial Interpretation
Ten Most Common Mistakes in Clinical Trial InterpretationTen Most Common Mistakes in Clinical Trial Interpretation
Ten Most Common Mistakes in Clinical Trial Interpretation
 
Navigating OCD in the world of 12 step Substance Use Disorder (SUD) Recovery
Navigating OCD in the world of 12 step Substance Use Disorder (SUD) RecoveryNavigating OCD in the world of 12 step Substance Use Disorder (SUD) Recovery
Navigating OCD in the world of 12 step Substance Use Disorder (SUD) Recovery
 
Breakout 3.4 How to support the psychological needs of patients with COPD - K...
Breakout 3.4 How to support the psychological needs of patients with COPD - K...Breakout 3.4 How to support the psychological needs of patients with COPD - K...
Breakout 3.4 How to support the psychological needs of patients with COPD - K...
 
Ten Most Common Mistakes in Clinical Trial Interpretation - Slidecast
Ten Most Common Mistakes in Clinical Trial Interpretation - SlidecastTen Most Common Mistakes in Clinical Trial Interpretation - Slidecast
Ten Most Common Mistakes in Clinical Trial Interpretation - Slidecast
 
Psychodynamics and Developmental Psychology of the Borderline Patient - a Rev...
Psychodynamics and Developmental Psychology of the Borderline Patient - a Rev...Psychodynamics and Developmental Psychology of the Borderline Patient - a Rev...
Psychodynamics and Developmental Psychology of the Borderline Patient - a Rev...
 
Critical appraisal of evidence/journal club
Critical appraisal of evidence/journal clubCritical appraisal of evidence/journal club
Critical appraisal of evidence/journal club
 
Moti messiah - ULD buprenorphine for suicidal ideation
Moti messiah - ULD buprenorphine for suicidal ideationMoti messiah - ULD buprenorphine for suicidal ideation
Moti messiah - ULD buprenorphine for suicidal ideation
 
PTSD
PTSDPTSD
PTSD
 

Ähnlich wie Carol Boyd

Ea 6 fingerson gay
Ea 6 fingerson gayEa 6 fingerson gay
Ea 6 fingerson gayOPUNITE
 
Comprehensive Psychiatric Evaluation Essay Discussion Paper.docx
Comprehensive Psychiatric Evaluation Essay Discussion Paper.docxComprehensive Psychiatric Evaluation Essay Discussion Paper.docx
Comprehensive Psychiatric Evaluation Essay Discussion Paper.docx4934bk
 
Drugs presentation 9.12.19.pptx
Drugs presentation 9.12.19.pptxDrugs presentation 9.12.19.pptx
Drugs presentation 9.12.19.pptxAnwar Siddiqui
 
Drugs / Substance Abuse
Drugs / Substance AbuseDrugs / Substance Abuse
Drugs / Substance AbuseAnwar Siddiqui
 
Substance abuse in special population
Substance abuse in special populationSubstance abuse in special population
Substance abuse in special populationmanishkumargoyal7
 
Gen rx power point
Gen rx power pointGen rx power point
Gen rx power pointprogroup
 
Drug abuse & misuse with explaination and examples
Drug abuse & misuse with  explaination and examplesDrug abuse & misuse with  explaination and examples
Drug abuse & misuse with explaination and examplesakberanum2016
 
Facts about barbiturates
Facts about barbituratesFacts about barbiturates
Facts about barbituratesNikki Ting
 
Addiction treatment models mammoura final
Addiction treatment models mammoura finalAddiction treatment models mammoura final
Addiction treatment models mammoura finalMPH_training_committee
 
Phil Walls
Phil WallsPhil Walls
Phil WallsOPUNITE
 
Rx16 prev wed_330_workplace issues and strategies
Rx16 prev wed_330_workplace issues and strategiesRx16 prev wed_330_workplace issues and strategies
Rx16 prev wed_330_workplace issues and strategiesOPUNITE
 
Cheif Presentation - Jerrold Frank Rosenbaum
Cheif Presentation - Jerrold Frank RosenbaumCheif Presentation - Jerrold Frank Rosenbaum
Cheif Presentation - Jerrold Frank Rosenbaumlamentiraestamuerta
 
Reducing Antipsychotic Drug Use for Dementia
Reducing Antipsychotic Drug Use for DementiaReducing Antipsychotic Drug Use for Dementia
Reducing Antipsychotic Drug Use for DementiaLeadingAge
 
Addiction as a disease.ppt
Addiction as a disease.pptAddiction as a disease.ppt
Addiction as a disease.pptDavidOmisi1
 
WEEK 6_ SPECIFIC APPROACHES TO OPIOID TREATMENT.pdf
WEEK 6_ SPECIFIC APPROACHES TO OPIOID TREATMENT.pdfWEEK 6_ SPECIFIC APPROACHES TO OPIOID TREATMENT.pdf
WEEK 6_ SPECIFIC APPROACHES TO OPIOID TREATMENT.pdfEmilyBailiff1
 
prescription-drug-abuse-alt (1).pdf
prescription-drug-abuse-alt (1).pdfprescription-drug-abuse-alt (1).pdf
prescription-drug-abuse-alt (1).pdfEbosoMweresa
 

Ähnlich wie Carol Boyd (20)

Ea 6 fingerson gay
Ea 6 fingerson gayEa 6 fingerson gay
Ea 6 fingerson gay
 
Comprehensive Psychiatric Evaluation Essay Discussion Paper.docx
Comprehensive Psychiatric Evaluation Essay Discussion Paper.docxComprehensive Psychiatric Evaluation Essay Discussion Paper.docx
Comprehensive Psychiatric Evaluation Essay Discussion Paper.docx
 
Drugs presentation 9.12.19.pptx
Drugs presentation 9.12.19.pptxDrugs presentation 9.12.19.pptx
Drugs presentation 9.12.19.pptx
 
Drugs / Substance Abuse
Drugs / Substance AbuseDrugs / Substance Abuse
Drugs / Substance Abuse
 
Substance abuse in special population
Substance abuse in special populationSubstance abuse in special population
Substance abuse in special population
 
Drug abuse
Drug abuseDrug abuse
Drug abuse
 
substance use.pptx
substance use.pptxsubstance use.pptx
substance use.pptx
 
Gen rx power point
Gen rx power pointGen rx power point
Gen rx power point
 
Medicines
MedicinesMedicines
Medicines
 
Drug abuse & misuse with explaination and examples
Drug abuse & misuse with  explaination and examplesDrug abuse & misuse with  explaination and examples
Drug abuse & misuse with explaination and examples
 
Facts about barbiturates
Facts about barbituratesFacts about barbiturates
Facts about barbiturates
 
Addiction treatment models mammoura final
Addiction treatment models mammoura finalAddiction treatment models mammoura final
Addiction treatment models mammoura final
 
Phil Walls
Phil WallsPhil Walls
Phil Walls
 
Rx16 prev wed_330_workplace issues and strategies
Rx16 prev wed_330_workplace issues and strategiesRx16 prev wed_330_workplace issues and strategies
Rx16 prev wed_330_workplace issues and strategies
 
Cheif Presentation - Jerrold Frank Rosenbaum
Cheif Presentation - Jerrold Frank RosenbaumCheif Presentation - Jerrold Frank Rosenbaum
Cheif Presentation - Jerrold Frank Rosenbaum
 
Reducing Antipsychotic Drug Use for Dementia
Reducing Antipsychotic Drug Use for DementiaReducing Antipsychotic Drug Use for Dementia
Reducing Antipsychotic Drug Use for Dementia
 
Addiction as a disease.ppt
Addiction as a disease.pptAddiction as a disease.ppt
Addiction as a disease.ppt
 
WEEK 6_ SPECIFIC APPROACHES TO OPIOID TREATMENT.pdf
WEEK 6_ SPECIFIC APPROACHES TO OPIOID TREATMENT.pdfWEEK 6_ SPECIFIC APPROACHES TO OPIOID TREATMENT.pdf
WEEK 6_ SPECIFIC APPROACHES TO OPIOID TREATMENT.pdf
 
De addiction
De addiction De addiction
De addiction
 
prescription-drug-abuse-alt (1).pdf
prescription-drug-abuse-alt (1).pdfprescription-drug-abuse-alt (1).pdf
prescription-drug-abuse-alt (1).pdf
 

Mehr von OPUNITE

Dr. Tom Frieden keynote
Dr. Tom Frieden keynoteDr. Tom Frieden keynote
Dr. Tom Frieden keynoteOPUNITE
 
Dr. Francis Collins keynote
Dr. Francis Collins keynoteDr. Francis Collins keynote
Dr. Francis Collins keynoteOPUNITE
 
Kana Enomoto keynote
Kana Enomoto keynoteKana Enomoto keynote
Kana Enomoto keynoteOPUNITE
 
Rx16 claad tue-vision_final
Rx16 claad tue-vision_finalRx16 claad tue-vision_final
Rx16 claad tue-vision_finalOPUNITE
 
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinnerRx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinnerOPUNITE
 
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershingWeb rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershingOPUNITE
 
Rx16 general session_wed_800_1_volkow copy
Rx16 general session_wed_800_1_volkow copyRx16 general session_wed_800_1_volkow copy
Rx16 general session_wed_800_1_volkow copyOPUNITE
 
Rx16 general session_900_1_botticelli
Rx16 general session_900_1_botticelliRx16 general session_900_1_botticelli
Rx16 general session_900_1_botticelliOPUNITE
 
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copyWeb rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copyOPUNITE
 
Rx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsenRx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsenOPUNITE
 
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingRx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingOPUNITE
 
Web only rx16 pharma-wed_330_1_shelley_2atwood-harless
Web only rx16 pharma-wed_330_1_shelley_2atwood-harlessWeb only rx16 pharma-wed_330_1_shelley_2atwood-harless
Web only rx16 pharma-wed_330_1_shelley_2atwood-harlessOPUNITE
 
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingRx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingOPUNITE
 
Rx16 len wed_330_1_ferdinand_2price
Rx16 len wed_330_1_ferdinand_2priceRx16 len wed_330_1_ferdinand_2price
Rx16 len wed_330_1_ferdinand_2priceOPUNITE
 
Rx16 heroin wed_330_1_rader_2lynch-earle
Rx16 heroin wed_330_1_rader_2lynch-earleRx16 heroin wed_330_1_rader_2lynch-earle
Rx16 heroin wed_330_1_rader_2lynch-earleOPUNITE
 
Rx16 clinical wed_330_1_saunders_2wexelblatt
Rx16 clinical wed_330_1_saunders_2wexelblattRx16 clinical wed_330_1_saunders_2wexelblatt
Rx16 clinical wed_330_1_saunders_2wexelblattOPUNITE
 
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4deanWeb only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4deanOPUNITE
 
Rx16 treat wed_200_group_falkinburg_miller
Rx16 treat wed_200_group_falkinburg_millerRx16 treat wed_200_group_falkinburg_miller
Rx16 treat wed_200_group_falkinburg_millerOPUNITE
 
Rx16 tpp wed_200_group
Rx16 tpp wed_200_groupRx16 tpp wed_200_group
Rx16 tpp wed_200_groupOPUNITE
 
Rx16 prevent wed_200_1_cairnes-wertnepy_2arnold
Rx16 prevent wed_200_1_cairnes-wertnepy_2arnoldRx16 prevent wed_200_1_cairnes-wertnepy_2arnold
Rx16 prevent wed_200_1_cairnes-wertnepy_2arnoldOPUNITE
 

Mehr von OPUNITE (20)

Dr. Tom Frieden keynote
Dr. Tom Frieden keynoteDr. Tom Frieden keynote
Dr. Tom Frieden keynote
 
Dr. Francis Collins keynote
Dr. Francis Collins keynoteDr. Francis Collins keynote
Dr. Francis Collins keynote
 
Kana Enomoto keynote
Kana Enomoto keynoteKana Enomoto keynote
Kana Enomoto keynote
 
Rx16 claad tue-vision_final
Rx16 claad tue-vision_finalRx16 claad tue-vision_final
Rx16 claad tue-vision_final
 
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinnerRx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
 
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershingWeb rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
 
Rx16 general session_wed_800_1_volkow copy
Rx16 general session_wed_800_1_volkow copyRx16 general session_wed_800_1_volkow copy
Rx16 general session_wed_800_1_volkow copy
 
Rx16 general session_900_1_botticelli
Rx16 general session_900_1_botticelliRx16 general session_900_1_botticelli
Rx16 general session_900_1_botticelli
 
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copyWeb rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
 
Rx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsenRx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsen
 
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingRx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
 
Web only rx16 pharma-wed_330_1_shelley_2atwood-harless
Web only rx16 pharma-wed_330_1_shelley_2atwood-harlessWeb only rx16 pharma-wed_330_1_shelley_2atwood-harless
Web only rx16 pharma-wed_330_1_shelley_2atwood-harless
 
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingRx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
 
Rx16 len wed_330_1_ferdinand_2price
Rx16 len wed_330_1_ferdinand_2priceRx16 len wed_330_1_ferdinand_2price
Rx16 len wed_330_1_ferdinand_2price
 
Rx16 heroin wed_330_1_rader_2lynch-earle
Rx16 heroin wed_330_1_rader_2lynch-earleRx16 heroin wed_330_1_rader_2lynch-earle
Rx16 heroin wed_330_1_rader_2lynch-earle
 
Rx16 clinical wed_330_1_saunders_2wexelblatt
Rx16 clinical wed_330_1_saunders_2wexelblattRx16 clinical wed_330_1_saunders_2wexelblatt
Rx16 clinical wed_330_1_saunders_2wexelblatt
 
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4deanWeb only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
 
Rx16 treat wed_200_group_falkinburg_miller
Rx16 treat wed_200_group_falkinburg_millerRx16 treat wed_200_group_falkinburg_miller
Rx16 treat wed_200_group_falkinburg_miller
 
Rx16 tpp wed_200_group
Rx16 tpp wed_200_groupRx16 tpp wed_200_group
Rx16 tpp wed_200_group
 
Rx16 prevent wed_200_1_cairnes-wertnepy_2arnold
Rx16 prevent wed_200_1_cairnes-wertnepy_2arnoldRx16 prevent wed_200_1_cairnes-wertnepy_2arnold
Rx16 prevent wed_200_1_cairnes-wertnepy_2arnold
 

Kürzlich hochgeladen

low cost antibiotic cement nail for infected non union.pptx
low cost antibiotic cement nail for infected non union.pptxlow cost antibiotic cement nail for infected non union.pptx
low cost antibiotic cement nail for infected non union.pptxdrashraf369
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdfDolisha Warbi
 
Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxKezaiah S
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!ibtesaam huma
 
Clinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseClinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseSreenivasa Reddy Thalla
 
maternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortalitymaternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortalityhardikdabas3
 
97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAAjennyeacort
 
Nutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience ClassNutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience Classmanuelazg2001
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdfDolisha Warbi
 
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...MehranMouzam
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...sdateam0
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptxMohamed Rizk Khodair
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurNavdeep Kaur
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfSasikiranMarri
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxSasikiranMarri
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxDr. Dheeraj Kumar
 
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxdrashraf369
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptxTina Purnat
 

Kürzlich hochgeladen (20)

low cost antibiotic cement nail for infected non union.pptx
low cost antibiotic cement nail for infected non union.pptxlow cost antibiotic cement nail for infected non union.pptx
low cost antibiotic cement nail for infected non union.pptx
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
 
Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptx
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!
 
Clinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseClinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies Disease
 
maternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortalitymaternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortality
 
Epilepsy
EpilepsyEpilepsy
Epilepsy
 
97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA
 
Nutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience ClassNutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience Class
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
 
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptx
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdf
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptx
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptx
 
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptx
 

Carol Boyd

  • 1. What Parents Can Do April 10-12, 2012 Walt Disney World Swan Resort
  • 2. Accepted Learning Objectives: 1. Compare mixed-method studies that focus on behavioral factors related to drug use and abuse, especially among youth and adolescents. 2. Outline proven comprehensive strategies for combating prescription drug abuse through the development of community partnerships. 3. Express the impact of prescription drug abuse on families and communities through anecdotal personal stories.
  • 3. Disclosure Statement •  All presenters for this session, Dr. Carol J. Boyd, Dr. Gary Martin, and Karen Perry, have disclosed no relevant, real or apparent personal or professional financial relationships.
  • 4. April 2012 Nonmedical Use of Controlled Medications among Teens Carol J Boyd, PhD, MSN, FAAN Deborah J Oakley Professor, Nursing Research Professor, UM Substance Abuse Research Center Co-Director, SHARP Center 4
  • 5. Purpose To meet the objectives, I will: •  Review the various ways in which the nonmedical use of controlled medications manifests itself in the adolescent population in the United States. •  Present definitions and case examples in order to highlight the complexity of this form of substance abuse. •  Using Problem Behavior Theory as a framework, we will focus on the behavioral and social problems that often accompany some forms of nonmedical use of controlled medications. 5
  • 6. Prescription Drug Abuse •  Medical misuse of controlled medications (drugs): –  use of a controlled medication by the person (and for the purpose) intended by the prescribing clinician; however, the medication is: •  NOT used in the prescribed dose and/or not taken within a prescribed time interval. It may also a different route of administration. •  Nonmedical use of controlled medications (drugs): –  use of a controlled medication to “get high”/create an altered state or –  for reasons other than what the prescribing clinician intended. •  Diversion of prescription medications (drugs): –  exchange of prescription medications that leads to the use of these drugs: •  by people other than whom the prescribing clinician intended or •  under conditions associated with “doctor shopping”/ misrepresentation •  by theft or drug dealing. 6
  • 8. Subtypes of Nonmedical Users Non-medical use of Controlled Medications Medication Diverted Misuse Sensation- Self-Treaters Seekers (With own Rx) (No Rx) Sensation- Self-Treaters (No Rx) Seekers (With own Rx) 8
  • 9. CASE EXAMPLES What do these subtypes look like? 9
  • 11. Case Example #1 A student is prescribed an SSRI and an anxiolytic (benzodiazepine) for Generalized Anxiety Disorder. He has been taking these medications for two years. During his junior year, the young man doubled his dose of the benzodiazepines (without physician knowledge) in order to reduce his anxiety; his symptoms were perceived as intolerable and he was seeking relief. 11
  • 12. Case Example #1: Behavior and Attributes BEHAVIOR: ATTRIBUTES: The intentional change •  Has his/her own prescription; in the dosing of a prescribed, scheduled •  Aware of the correct dosing instructions; medication for the purpose of relieving the •  Motive is to reduce symptoms from a symptoms for which the medical disorder. medication was originally prescribed. Self-treatment w/ own Rx 12
  • 13. Case Example #2  A young man is prescribed a stimulant for his ADHD and to assist with concentration. He takes the medication as prescribed during the week; on the weekend he often snorts his medicine and goes out drinking with friends. 13
  • 14. Case Example #2: Behavior and Attributes   ATTRIBUTES: BEHAVIOR: •  Administered in ways other The incorrect use of than prescribed; a prescribed •  Used in higher doses either medication by a by increasing the dosage or patient with a by decreasing the time- prescription.     interval between doses; •  Motive is to enhance the medication’s effect in order to get high, experience an altered state or increase performance. Sensation-seeking w/ own rx 14
  • 15. Case Example #3 On a Friday afternoon, a 16 year old teen, an honor student, is planning to attend “Homecoming” with her new boyfriend. Four hours before the event, she develops a severe migraine and is nauseated and dizzy. In tears, she asks her mother for help. Her mother gives her two hydrocodone tablets (left over from her own surgery). The teen went to the event and “had a great time.” 15
  • 16. Case Example #3: Behavior and Attributes BEHAVIOR: ATTRIBUTES: •  No prescription; The intentional use of •  Perceived barriers to someone else’s medical care (a prescription medication prescription is not for the purpose of available); alleviating symptoms •  Motive to relieve a that may be related to condition for which the a health problem. medication, when prescribed, is generally intended.     Self-treatment w/o legal rx 16
  • 17. Case Example #4 A girl with a history of alcohol abuse is given an oxycodone tablet by a friend; she wants to experiment to see “what it does”. She crushes and snorts the pill. The girl continues to buy “Oxy” from friends when she wants to party. 17
  • 18. Case Example #3: Behavior and Attributes DEFINITION: ATTRIBUTES: •  No prescription; The use of a •  May involve using in controlled combination with other medication to drugs experiment, to get •  May involve delivering the high or to create an medication in a wrongful altered state. manner (e.g. IV, skin- popping, snorting, smoking). •  Motive is to experiment, get high or to alleviate withdrawal symptoms Sensation-seeking w/o legal rx 18
  • 19.  Should it Matter? Our PRELIMINARY work showed: –  Increased risk with some motivations –  When respondents report using their scheduled medications correctly, there is no greater risk for using illicit drugs than non-users. –  When respondents divert their medications, they are more likely to engage in other forms of substance use. –  Sharing/selling and taking/borrowing/buying involve differential health and social consequences. 19
  • 20. Prescription Drug Misusers & Abusers: Subtypes Person does not possess Person does possess legal legal prescription prescription Sensation-seeking: Sensation-seeking: get high, experiment, or create get high, experiment, or create altered state (w/ someone else’s altered state (w/ own meds) meds) Self-treating: Self-treating: self-treat symptoms of actual or self-treat symptoms of actual perceived health condition (w/ or perceived health condition someone else’s meds) (w/ own meds) Boyd CJ, McCabe SE. Subst Abuse Treat Prev Policy. 2008,3:22.
  • 21. IS THIS CONCEPTUALIZATION SUPPORTED BY DATA? Do subtypes matter .
  • 22. Background •  Boyd, C.J., McCabe, S.E., & Teter, C.J. (2006). Medical and Nonmedical Use of Prescription Pain Medication by Youth in a Detroit-Area Public School District. Drug and Alcohol Dependence, 81(1): •  In the past, our team has 37-45. published on motivations, •  Boyd, C.J., McCabe, S.E., Cranford, J.A., & Young, diversion and problem A.M. (2006). Adolescents’ Motivations to Abuse Prescription Medications. Pediatrics, 118:2472-2480. behaviors associated with •  Boyd, C.J., McCabe, S.E., Cranford, J.A., & Young, the nonmedical use of A.M. (2007). Gender Differences in Prescription Drug Abuse and Diversion among Adolescents in a scheduled medications by Southeast Michigan School-District. Archives of Adolescent and Pediatric Medicine, 161: 276-281. adolescents. •  McCabe, S.E., Boyd, C.J., Young, A.M. (2007) Medical and Nonmedical Use of Prescription Drugs among Secondary School Students. Journal of •  Our procedures and Adolescent Health, 40: 76-83. measures have been •  Boyd, C.J., Young, A.M., Grey, M., & McCabe, S.E. (2009). Adolescents’ nonmedical use of prescription described previously in medications and other problem behaviors. Journal of Adolescent Health. 45, 543-550. great detail. •  Young, A.M, Grey, M., McCabe, S.E., Boyd, C.J. (In Press). Adolescent Sexual Assault and the Medical and Nonmedical Use of Prescription Medication. Journal of Addiction Nursing. NIH GRANT R01 DA024678
  • 23. Problem Behaviors and Nonmedical Use . 23
  • 24. Conceptual Model: Problem Behavior Theory (Adapted from Jessor) Substance Medical Misuse/ Abuse Non-medical Use Problems Personal Risk factors • Medical/Psychiatric care of Rx Drugs • Social Environment • Medications • Truancy • Perceived Environment • Peers/social network • Gambling • Demographic • Medical problems • Early sexual activity • Family Support • CRAFFT Characteristics • Genetics/biology • Emotional problems • Resilience/Vulnerability • School activities • MOTIVATIONS • Illicit drug use • DAST-10 • School-based counseling • Sensation-Seeking • Psychological • Personality • Self-treatment Domains Problem Symptom Behaviors relief Boyd, C.J., Young, A., Grey, M., & McCabe, S.E., 2009. Adolescents’ nonmedical use of prescription medications and other problem behaviors. J Adol. Health 45, 539-540. Boyd (PI) NIH Grant RO1 DA024678
  • 25. Hypothesis Youth engaging in nonmedical use for sensation-seeking are more likely to report other problem behaviors vs. those who are: –  non-users (who were never prescribed an opioid) –  medical users (who were prescribed but used correctly) –  self-treaters (who engaged in nonmedical use for self-treatment) Boyd CJ, et al. J Adolesc Health. 2009;45:543-50.
  • 26. Problem Behaviors and Nonmedical Use •  Administered to grades 7-12 (912 respondents in 2007) southeastern Michigan school district –  Random sample, Web-based, self-administered –  Secondary Student Life Survey “On how many occasions in past 12 months have you used the following types of drugs, not prescribed to you?” (also asked about lifetime use) –  Sleeping medication –  Sedative/anxiety medication –  Stimulant medication –  Pain medication Boyd CJ, et al. J Adolesc Health. 2009;45:543-50.
  • 27. Sample Characteristics Female: 52.6% Mean Age: 14.97 (1.74) (480) Black: 53.8% (490) Male: 47.4% White: 43.5% (396) (432) Asian American: 1.4% (13) Total: 912 Hispanic/ Latino/a: .7% (6) American/Alaskan Native: .7% (6) 27
  • 28. Procedure: Secondary Student Life Survey •  Data were collected, w/web-based survey •  All students in one school district (7th-12th grades) •  968 students returned consent forms (64% response rate) •  IRB approval was obtained, hooded computers used •  The Secondary Student Life Survey (SSLS) is maintained on a hosted secure Internet site running under the secure sockets layer (SSL) protocol to insure data were safely transmitted. 28
  • 29. Measures •  Demographic information. •  Binge drinking. Illicit drug use. •  Illicit drug use was assessed •  Gambling. •  School discipline. •  Sexual activity. •  Depression (CESD scale). Depression symptoms were measured by the Center for Epidemiological Studies Depression Scale.  •  Impulsivity. The Impulsivity subscale, part of the Impulsivity/Sensation-Seeking scale (Imp-SS) of the Zuckerman-Kuhlman Personality Questionnaire. 29
  • 30. Characteristics of Respondents Past-Year Use (Pain, Stimulant, Anti-anxiety/Sedative & Sleep) Secondary Student Life Survey Boyd CJ, et al. J Adolesc Health. 2009;45:543-50.
  • 31. Prevalence of Medical & Nonmedical Use Medical use Nonmedical use *Often for third molar extractions Boyd CJ, et al. J Adolesc Health. 2009;45:543-50.
  • 32. Past-yr Problem-Behaviors: Medical & Nonmedical Users Secondary Student Life Survey *P<.05 vs. all 3 other gps †P<.05 vs. nonusers & medical users * Non-users: reference gp set to “0” * * Boyd CJ, et al. J Adolesc Health. 2009;45:543-50.
  • 33. Summary •  The nonmedical use of controlled medications involves a variety of behaviors; •  Consequences may be different for self- treaters versus sensation-seekers; •  Prevention experts must decide behaviors they are targeting; •  Everyone plays a role in prevention •  Consider the ABC’s… 33
  • 34. Our team’s next project ABC’s and Prevention Boyd, C.J., Anderson, K.G., Rieckman, T. (2011) ABC’s of Controlled Medications: What Patients Need to Know about their Prescription Pain Medicine (Commentary), Journal of Addictions Nursing. 22:1–3.
  • 35.
  • 36.
  • 37. QUESTIONS? THANK YOU